Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
p53 Mutant Mice with Altered Cancer and Aging Phenotypes Larry Donehower Baylor College of Medicine Houston, Texas 77030 p53 - A Major Node in the Cellular Stress Response ROS Hypoxia Oncogenes p53 mdm2 Cell Cycle Arrest Transient IR,UV Apoptosis ? ? Senescence SirT1 p66Shc Terminal Telomere loss ? Organismal Aging?? 100 p53+/+ n = 56 % SURVIVORS 80 p53+/60 n = 217 40 p53-/n = 72 20 0 0 0.5 1.0 1.5 AGE (YEARS) 2.0 2.5 3.0 ABERRANT GENE TARGETING INTRODUCES A p53 DELETION Wild Type p53 Allele 1 * 4 5 11 8 7 Aberrant Gene Targeting deletion 1-6 “m” p53 Allele Pr * 8 7 “m” mRNA 11 AAA AUG Truncated C-terminal p53 fragment Missing: Transactivation domain DNA binding domain p53 a.a. 240-390 “m” protein M allele mRNA is translated into a C-terminal truncated p53 protein in vitro and in vivo In vitro translation of m allele message. IP with p53 Ab PAb421 WT C m protein Interacts with Wt p53 in vitro m protein present in tissues p53+/m mice GST GST-p53 m + m + m + m + m - m 53 kd 24 kD 24 kD 24 kD 7 kD Spleen Kidney Heart Liver Saos2 Possible Effects of m Protein on Tumorigenesis No Effect (Null Allele) m Oncogenic Effect Tumor Suppressor Effect p53+/m --> tumors same as p53+/- p53+/m --> tumors before p53+/- p53+/m --> tumors later than p53+/- p53 +/m mice have reduced longevity 1 Cumulative Survival .8 p5 3+/+ N= 5 6 45 % TUM .6 p5 3+/m N= 3 5 6% TUM .4 p53+/N= 217 > 80% TUM .2 0 0 20 40 60 80 100 120 140 Age (Weeks) +/m medium lifespan = 96 weeks +/+ median lifespan = 118 weeks 160 p53 +/m mouse phenotype p53 +/+ p53 +/m • • • • • • • • Tumor resistance • Reduced longevity • Reduced body weight Osteoporosis Lordokyphosis Organ atrophy Decreased regeneration & stress tolerance Mice appear normal until 12 months, overt phenotype by 16-18 months. Age-associated organ atrophy in p53 +/m mice and humans Humans p53 +/+ p53 +/m Mice Body Spleen Liver Kidney Osteoporosis in the p53 +/m mouse p53 +/+ p53 +/m Skin Atrophy in p53+/m Mice p53+/+ 3 mo p53+/m 3 mo p53+/+ 24 mo p53+/m 24 mo Muscle atrophy in 24 month p53+/m mice Muscle Mass (mg) 150 100 50 0 p53+/+ p53+/m p53 +/m mouse exhibits a decreased regenerative response Wound healing: +/m +/+ 3M mice 24M mice • Re-epithelization of skin following 3mm biopsy punch. • 24 month p53 +/m mice show reduced ability to close wound. Aging Phenotypes of p53 +/m Mice Phenotype Median Life Span Maximum Life Span Cancer Incidence Body Weight Organ Weights (24m) Lymphoid Atrophy Lordokyphosis Osteoporosis Blood Chemistry Peripheral WBC, RBC Counts Male Fecundity Hair Graying and Alopecia Hair Regrowth Dermal Thickness Subcutaneous Adipose Wound Healing Muscle Atrophy Tolerance Anesthetic Stress 5-FU Myeloablation p53+/+ 118 weeks 164 weeks >45% Reduced by 30m Minimal loss Moderate Modest Minimal Normal Normal Normal Minimal Modestly Reduced Moderately Reduced Moderately Reduced Normal Re-epithelialization Moderate Good Robust WBC p53+/m 96 weeks 136 weeks <6% Reduced by 18m 25-40% loss Pronounced Pronounced Pronounced Normal Normal Normal Minimal Greatly Reduced Greatly Reduced Greatly Reduced Reduced Re-ep. Pronounced Poor Reduced WBC Senescence-associated beta galactosidase assay 1. Assay, developed by Campisi and colleagues, is specific for senescent cells. Quiescent, presenescent, or immortal cells not stained. 2. Senescent cells stain blue when incubated at pH 6.0 with X-gal. 3. Recently, we have tested this assay in fixed tissues in situ (below is a 20 month p53+/m liver section with blue stained senescent cells). 21 month +/m Liver Old p53+/m mice show higher percentages of senescent liver cells Senesence Associated B-galactosidase Assay: Liver 12 % Senescent Cells 10 8 6 4 2 0 p53 +/+ p53 +/+ p53 +/m p53 +/m 3 month 21 month 3 month 21 month Old p53+/m mice show higher percentages of senescent spleen cells Senescence Associated B-galactosidase Assay: Spleen 3 % Senescence 2.5 2 1.5 1 0.5 0 p53 +/+ p53 +/+ 3 month 21 month p53 +/m p53 +/m 3 month 21 month Proposed model of m function C-Term TA DNA Damage Oncogenes TA DNA Bind Latent WT p53 P Ac P Removal of stressors C-Term DNA Bind Activated WT p53 Cell cycle arrest Apoptosis Senescence m TA C-Term P DNA Bind TA Latent WT p53 P Ac DNA Bind Activated WT p53 C-Term Elevated p53 levels and stability in the presence of the m protein • Before and after 5G g-IR Mice with Increased p53 Activity Our Lab Cancer Resistance p53+/m Early Aging Phenotypes Mut p53 WT p53 WT p53 TG Serrano Super p53 Cancer Resistance Normal Aging WT p53 WT p53 Scrable Runted Mice Truncated p53 Transgenic Early Aging Phenotypes Mut p53 TG WT p53 WT p53 Tissue stem cells and aging • Adult tissue stem cells are critical for maintaining organ cellularity and function (homeostasis). • Multiple adult stem cells have been shown to exhibit agerelated decline in functionality. • Relative reduction of HSC functionality may vary with mouse strain longevity (Van Zant). • p53+/m mice exhibit early organ atrophies and reduced regenerative responses, suggesting earlier failures in maintaining organ homeostasis. • These p53+/m phenotypes suggest an earlier age-associated reduction in stem cell functionality. Cobblestone Frequency Frequency (per 000 Cobblestone (per100, 100, 000 cells) cells) Young HSC numbers 35 35 30 30 25 25 WWT T 20 20 +/+/+/m +/m 15 15 -/-/- 10 10 5 5 0 0 D7 D7 D14 D14 D21 D21 Days of Culture D28 D28 D35 D35 Days of Culture • • p53 +/m mice appear to have reduced numbers of progenitor HSC compared to p53 +/+, +/- and -/- mice. No significant difference between the p53 +/+, +/- and -/- mice. 60 60 50 Cells (%) Percentage of Proliferating Percentage of Proliferating Cells (%) Young HSC proliferation 40 50 40 30 30 20 20 10 10 0 0 WT WT +/- +/- -/- -/- +/m +/m p53 Genotype p53 Genotypes • p53 -/- and +/- HSC proliferative index approximately two fold more than +/+ and +/m counterparts. • These results comparable to the MSC proliferation profile. Analysis of SP-HSC in p53 +/+ and +/m mice p53 +/+ Sca-1+= 36.62% p53 +/m Sca-1+= 18.97% SP cells are selected from total bone marrow by Hoechst/PI sorting. Pure SP cells are identified by selection of Sca-1+ and GR-1- cells. Reduced Numbers of p53+/m Sca-1+ SP Stem Cells in Marrow 18 month old mice 0.09 Percentage of Sca+ SP SP cells inin total Percentage of Sca+ cells totalbone bone marrow (%) marrow (%) 0.09 0.08 0.08 0.07 0.07 0.06 0.06 0.05 0.05 0.04 0.04 0.03 0.02 0.03 0.01 0.02 0 0.01 WT +/- +/m p53 Genotypes 0 WT +/p53 Genotypes +/m DOES p53 DOSAGE AFFECT STEM CELL FUNCTION? TUMOR p53+/- Stem Cell Functional Capacity Homeostasis p53+/+ p53+/m Reduced Cellularity Reduced Function Reduced Stress Tolerance Death Acknowledgements Donehower Lab Baylor Gerard Karsenty Dennis Roop Stuart Tyner Jene Choi Nader Ghebranious Sundaresan Venkatachalam Xiongbin Lu Herbert Igelmann Cory Brayton Peggy Goodell Melissa Dumble Monica Justice Andy Salinger Bradley Lab Kentucky Allan Bradley Steve Jones Gary Van Zant National Cancer Institute National Institute on Aging